| Product Code: ETC10402159 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Israel`s import shipments of recombinant hormones continued to showcase a high level of market concentration, with top exporting countries including Switzerland, USA, Germany, China, and Belgium. The market saw a significant decline in CAGR from 2020 to 2024 at -13.88%, but there was a positive growth rate of 8.63% from 2023 to 2024. This data suggests a dynamic landscape for recombinant hormone imports in Israel, with potential opportunities for further market expansion and diversification in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Recombinant Hormone Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Recombinant Hormone Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Recombinant Hormone Market - Industry Life Cycle |
3.4 Israel Recombinant Hormone Market - Porter's Five Forces |
3.5 Israel Recombinant Hormone Market Revenues & Volume Share, By Hormone Type, 2021 & 2031F |
3.6 Israel Recombinant Hormone Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Recombinant Hormone Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Israel Recombinant Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hormone-related disorders in Israel |
4.2.2 Growing awareness and acceptance of recombinant hormone therapies |
4.2.3 Technological advancements in recombinant hormone production and delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of recombinant hormone products |
4.3.2 High cost associated with recombinant hormone therapies |
4.3.3 Limited availability of recombinant hormone products in certain regions of Israel |
5 Israel Recombinant Hormone Market Trends |
6 Israel Recombinant Hormone Market, By Types |
6.1 Israel Recombinant Hormone Market, By Hormone Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Recombinant Hormone Market Revenues & Volume, By Hormone Type, 2021 - 2031F |
6.1.3 Israel Recombinant Hormone Market Revenues & Volume, By Insulin, 2021 - 2031F |
6.1.4 Israel Recombinant Hormone Market Revenues & Volume, By Growth Hormone, 2021 - 2031F |
6.1.5 Israel Recombinant Hormone Market Revenues & Volume, By Erythropoietin, 2021 - 2031F |
6.2 Israel Recombinant Hormone Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Recombinant Hormone Market Revenues & Volume, By Diabetes Management, 2021 - 2031F |
6.2.3 Israel Recombinant Hormone Market Revenues & Volume, By Growth Disorders, 2021 - 2031F |
6.2.4 Israel Recombinant Hormone Market Revenues & Volume, By Anemia Treatment, 2021 - 2031F |
6.3 Israel Recombinant Hormone Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Israel Recombinant Hormone Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.3 Israel Recombinant Hormone Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.4 Israel Recombinant Hormone Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
7 Israel Recombinant Hormone Market Import-Export Trade Statistics |
7.1 Israel Recombinant Hormone Market Export to Major Countries |
7.2 Israel Recombinant Hormone Market Imports from Major Countries |
8 Israel Recombinant Hormone Market Key Performance Indicators |
8.1 Average time to market approval for new recombinant hormone products in Israel |
8.2 Patient adherence rates to recombinant hormone therapies |
8.3 Number of clinical trials focusing on new recombinant hormone treatments in Israel |
9 Israel Recombinant Hormone Market - Opportunity Assessment |
9.1 Israel Recombinant Hormone Market Opportunity Assessment, By Hormone Type, 2021 & 2031F |
9.2 Israel Recombinant Hormone Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Recombinant Hormone Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Israel Recombinant Hormone Market - Competitive Landscape |
10.1 Israel Recombinant Hormone Market Revenue Share, By Companies, 2024 |
10.2 Israel Recombinant Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |